Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000091829

Apexbio Technology LLC Anti-CTLA-4/CD152 Antibody (Ipilimumab) 5mg
SDP

Supplier:  Apexbio Technology LLC F12215

Encompass_Preferred

Ipilimumab (CAS 477202-00-9) is a fully human monoclonal antibody targeting cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4/CD152) an inhibitory receptor expressed on activated T cells It is designed to block the interaction between CTLA-4 and its ligands CD80/CD86 thereby modulating inhibitory signaling pathways affecting T cell-mediated immune responses Ipilimumab exerts its biological activity primarily through specific binding to CTLA-4 thus regulating immune checkpoint signaling Based on these pharmacological properties Ipilimumab holds research potential in studies focusing on CTLA-4-mediated immune regulation and investigative models addressing unresectable or metastatic melanoma

Catalog No. 50-000-91829


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.